topic

MYCOBACTERIUM TUBERCULOSIS RESISTANCE TO ISONIAZID AND RIFAMPICIN IN A HIV-1 ENDEMIC POPULATION IN WESTERN KENYA IN 2014
Clement Likhovole, Collins Ouma, John Vulule, Susan Musau, Jeremiah Khayumbi, Albert Okumu, Wilfred Murithi

BMJ Global Health Feb 2017, 2 (Suppl 2) A32; DOI: 10.1136/bmjgh-2016-000260.84
ANTIBODY RESPONSES TO SURFACE ANTIGENS OF PLASMODIUM FALCIPARUM GAMETOCYTE-INFECTED ERYTHROCYTES AND THEIR RELATION TO GAMETOCYTAEMIA
Bismarck Dinko, Elizabeth King, Geoffrey Targett, Colin Sutherland

BMJ Global Health Feb 2017, 2 (Suppl 2) A32; DOI: 10.1136/bmjgh-2016-000260.83
ROAD TO BUILDING AND SUSTAINING NOVEL CLINICAL RESEARCH CAPACITY IN RESOURCE-LIMITED SETTINGS: LESSONS LEARNT SO FAR FROM RWANDA
Clarisse Musanabaganwa, Jean Pierre Musabyimana, Etienne Karita, Blondin Diop, Abidan Nambajimana, Valentine Dushimiyimana, Prosper Karame, Jim Russell, Jules Ndoli, Prince Bahati, Theobald Hategekimana, Augustin Sendegeya, Jeannine Condo, Agnes Binagwaho

BMJ Global Health Feb 2017, 2 (Suppl 2) A33; DOI: 10.1136/bmjgh-2016-000260.86
NEED FOR REANALYSIS OF CURRENT TESTING OF HIV-EXPOSED INFANTS
Emmanuel Saka, Zex Kalipalire, Ravikiran Bhairavabhotla, Dalitso Midiani, Judith Sherman

BMJ Global Health Feb 2017, 2 (Suppl 2) A34; DOI: 10.1136/bmjgh-2016-000260.89
MOLECULAR TYPING AND DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS COMPLEX ISOLATES FROM JAMOT AND MBALMAYO DISTRICT HOSPITALS, CAMEROON
Emmanuel Mouafo Tekwu, Larissa Kamgue Sidze, Jean Paul Assam Assam, Sarah Eyangoh, Stefan Niemann, Francine Ntoumi, Veronique Penlap Beng, Matthias Frank

BMJ Global Health Feb 2017, 2 (Suppl 2) A35; DOI: 10.1136/bmjgh-2016-000260.92
DISCORDANT RESULTS BETWEEN GENOTYPIC ASSAYS (XPERT MTB/RIF AND HAIN MTBDRPLUS) AND BACTEC MGIT 960 SYSTEM FOR DETECTION OF RIFAMPICIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATES IN ZAMBIA
Winnie Mwanza, Deborah Milimo, Maureen Moyo, Nkatya Kasese, Maina Cheeba-Lengwe, Stembiso Munkondya, Helen Ayles, Petra De Haas, Monde Muyoyeta

BMJ Global Health Feb 2017, 2 (Suppl 2) A36; DOI: 10.1136/bmjgh-2016-000260.95
VITAMIN D FOR TREATMENT AND PREVENTION OF TB-HIV
Anna Coussens, Celeste Naude, George Chaplin, Mahdad Noursadeghi, Adrian Martineau, Nina Jablonski, Robert Wilkinson

BMJ Global Health Feb 2017, 2 (Suppl 2) A37-A38; DOI: 10.1136/bmjgh-2016-000260.99
CYTOLOGICAL PROFILE OF RED BLOOD CELLS IN HIV-INFECTED PATIENTS: CASE OF THE DOUALA GENERAL HOSPITAL (CAMEROON)
Amel Bidias, Dieudonné Ndjonka, Clémence Olemba, Arabo Souleymanou

BMJ Global Health Feb 2017, 2 (Suppl 2) A38-A39; DOI: 10.1136/bmjgh-2016-000260.101
PHARMACOKINETICS OF RIFABUTIN IN COMBINATION WITH LOPINAVIR-RITONAVIR IN ADULT PATIENTS WITH HIV AND TUBERCULOSIS CO-INFECTION IN BURKINA FASO
Henri Gautier Ouedraogo, Alberto Matteelli, Mario Regazzi, Grissoum Tarnagda, Paola Villani, Giorgia Sulis, Serge Diagbouga, Alberto Roggi, Francesco Giorgetti, Seni Kouanda

BMJ Global Health Feb 2017, 2 (Suppl 2) A38; DOI: 10.1136/bmjgh-2016-000260.100
RELATIONSHIP OF HIV-HBV CO-INFECTION WITH CD4 CELL COUNT AND ALANINE TRANSAMINASE LEVELS IN ANTI-RETROVIRAL THERAPY-NAïVE PATIENTS
Kalo Musukuma, Roma Chilengi, Rosalia Dambe, Benjamin Usadi, Michael Vinikoor

BMJ Global Health Feb 2017, 2 (Suppl 2) A40-A41; DOI: 10.1136/bmjgh-2016-000260.107

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages